Zyryanov, S. K., & Butranova, O. I. (2022). New opportunities for lowering low-density lipoprotein cholesterol: Comparative characteristics of PCSK9-targeted therapy. «FIRMA «SILICEA» LLC.
Chicago Style (17th ed.) CitationZyryanov, S. K., and O. I. Butranova. New Opportunities for Lowering Low-density Lipoprotein Cholesterol: Comparative Characteristics of PCSK9-targeted Therapy. «FIRMA «SILICEA» LLC, 2022.
MLA (9th ed.) CitationZyryanov, S. K., and O. I. Butranova. New Opportunities for Lowering Low-density Lipoprotein Cholesterol: Comparative Characteristics of PCSK9-targeted Therapy. «FIRMA «SILICEA» LLC, 2022.
Warning: These citations may not always be 100% accurate.